Sections View Full Chapter Figures Tables Videos Annotate Full Chapter Figures Tables Videos Supplementary Content ++ Chronic hypertension:Systolic blood pressure >140 mm Hg or diastolic blood pressure >90 mm Hg prior to pregnancy of before 20 weeks of gestationHypertension that persists beyond the 12th postpartum weekGestational hypertension:New-onset hypertension after midpregnancy without proteinuria that resolves within 12 weeks postpartumPreeclampsia:New-onset hypertension after 20 weeks gestation associated with >300 mg per day proteinuriaNew-onset seizures in the setting of preeclampsia are defined as eclampsiaPreeclampsia superimposed on chronic hypertension ++Table Graphic Jump Location|Download (.pdf)|PrintHemodynamic Characteristics of Hypertensive Disorders during Pregnancy1HealthyEarly preeclampsiaLate preeclampsiaGestational or chronic hypertensionCardiac output6.28.95.09.0Systemic vascular resistance1,2101,0821,687922Wedge pressure7.59137Stroke volume8010458110LVSWI48613364Colloid oncotic pressure181714181No ranges are given; numbers are presented for comparison as representative values. ++Table Graphic Jump Location|Download (.pdf)|PrintChronic HypertensionAffects 3% of pregnant populationMore common inAfrican Americans (up to 44%)Older gravidas (>12% after the age of 35) Frequently associated with obesity, diabetes mellitusMaternal complicationsSuperimposed preeclampsia10–25% incidence of progression to preeclampsia2.7-fold increase in risk for severe preeclampsiaPlacental abruptionCommonly used oral medications1α-MethyldopaLabetalolMetoprolol SR is an alternativeNifedipine SRLess commonly used oral medications1HydrochlorothiazideHydralazine (oral)Fetal complicationsIUGR/low birth rateFetal demiseContraindicated in pregnancy1ACEIs, ARBs, direct renin inhibitorsPropranolol (atenolol)1Pharmacological options for the treatment of gestational hypertension are the same as those for chronic hypertension. ++Table Graphic Jump Location|Download (.pdf)|PrintPreeclampsiaEstimated frequency in healthy nulliparous women is 2–7%Majority of cases (75%): mild, near term or intrapartum onset, negligible increase in risk for adverse outcomeFrequency and severity is higher with history ofMultiple gestationChronic hypertensionPrior pregnancy with preeclampsiaPregestational diabetes mellitusThrombophiliaMaternal complicationsPlacental abruption (1–4%)Disseminated coagulopathy/HELLP syndrome (10–20%)Pulmonary edema/aspiration (2–5%)Acute renal failure (1–5%)Eclampsia (1%)Liver failure or hemorrhage (1%)Stroke (rare)Death (rare)Long-term cardiovascular morbidityDiagnosis and management is supported by adequate prenatal careMain objective remains the safety of the motherExpectant management for pre-34 weeks remains controversialMultisystem disorder with poorly understood pathomechanismAbnormal vascular response to placentationPlacental humoral factors (sFlt-1, sEng) cause endothelial dysfunction in motherUnique to human pregnancyCharacterized byMicrovascular dysfunctionIncreased SVRActivation of inflammatory pathwaysEnhanced coagulationIncreased platelet activation and aggregationEndothelial barrier dysfunctionPreeclampsia is most likely the common manifestation of a number of diseases affecting pregnant womenFetal effectsIUGR/low birth weightReduced amniotic fluidRestricted placental oxygen exchange, fetal hypoxia and neurological injuryPreterm deliveryAntihypertensivesLittle evidence for benefit in mild/moderate casesSevere hypertension (>160 mm Hg systolic, >100 mm Hg diastolic) should be treated to prevent maternal end-organ damageHydralazine was associated with more maternal side effects ... Your Access profile is currently affiliated with [InstitutionA] and is in the process of switching affiliations to [InstitutionB]. Please select how you would like to proceed. Keep the current affiliation with [InstitutionA] and continue with the Access profile sign in process Switch affiliation to [InstitutionB] and continue with the Access profile sign in process Get Free Access Through Your Institution Learn how to see if your library subscribes to McGraw Hill Medical products. Subscribe: Institutional or Individual Sign In Error: Incorrect UserName or Password Username Error: Please enter User Name Password Error: Please enter Password Sign in Forgot Password? Forgot Username? Sign in via OpenAthens Sign in via Shibboleth You already have access! Please proceed to your institution's subscription. Create a free profile for additional features.